Attached files
file | filename |
---|---|
EX-31.2 - EX-31.2 - Ovid Therapeutics Inc. | ovid-20210630ex31_2.htm |
EX-31.1 - EX-31.1 - Ovid Therapeutics Inc. | ovid-20210630ex31_1.htm |
EX-10.1 - EX-10.1 - Ovid Therapeutics Inc. | ovid-20210630ex10_1.htm |
10-Q - 10-Q - Ovid Therapeutics Inc. | ovid-20210630.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Jeremy M. Levin, Chief Executive Officer of Ovid Therapeutics Inc. (the “Company”), and Jeffrey Rona, Chief Business and Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:
Dated: August 13, 2021
/s/ Jeremy M. Levin |
|
/s/ Jeffrey Rona |
Jeremy M. Levin |
|
Jeffrey Rona |
Chief Executive Officer (Principal Executive Officer) |
|
Chief Business and Financial Officer (Principal Financial and Accounting Officer) |